NEW YORK, NY, Oct. 04, 2021 (GLOBE NEWSWIRE) — Love Pharma Inc. (CSE: LUV), previously Glenbriar Applied sciences, Inc., is a new-age pharma/nutraceutical firm that focuses on the worldwide sexual well being, wellness and psychedelics markets by licensing and distributing psychedelic and cannabis-infused merchandise. The corporate ushered in a brand new period of well being and wellness because it started buying and selling on the Canadian Securities Change final week beneath the brand new identify and ticker image.
As Love Pharma units out to carry psychedelic therapies, pharmaceutical alternate options, and sexual enrichment merchandise to market, it is going to instantly propel its present CBD-infused manufacturers, “Bloom” and “Auralief,” into {the marketplace} whereas it continues to develop a bunch of extra patent-protected merchandise within the firm’s pipeline. https://love-pharma.com/products
Love Pharma’s Chief Govt Officer (CEO), Zachary Stadnyk, a long-time company finance advisory skilled, is not any stranger to launching firms within the public area. And he and his crew have positioned the corporate to compete in three fast-growing markets—two are extensively in style, the worldwide CBD market, and the worldwide sexual well being and wellness market, whereas the opposite is an rising however quickly rising market, the worldwide psychedelic market, aka, the “shroom growth.”
To that finish, Love Pharma acquired BC-based Kick Prescription drugs, a specialised well being and wellness firm, and with the acquisition gained the unique rights and licenses to provide, market, package deal, promote and distribute six pharmaceutical and therapeutic merchandise all through Europe, North America, and the UK.
Love Pharma’s imaginative and prescient is to develop merchandise that focus on each psychological and sexual well being to enhance the standard of on a regular basis life for all people. The sheer recognition of the markets, during which Love Pharma will compete, gives myriad alternatives for growth in North America and on the worldwide stage with an array of high-demand merchandise.
First, when growing nutraceuticals, the corporate focuses on pharmaceutical-alternative substances with physiological advantages, reminiscent of CBD and THC, which might be present in each of its preliminary merchandise. Love Pharma’s first nutraceutical merchandise, embody Bloom, a topical gel infused with CBD and/or THC, that will increase blood stream and sensitivity, and Auralief CBD oral strips, the corporate’s discreet cannabis-infused oral strip that speeds-up and enhances the specified results of THC and CBD.
One market benefit that Love Pharma will take pleasure in over lots of its rivals throughout its improvement course of is the corporate’s demand for scientific validation. Love Pharma helps its merchandise with as a lot analysis and scientific knowledge as potential. For example, Bloom is clinically confirmed to extend the quantity, depth, and velocity of orgasms in girls, and Auralief is supported by a current human trial that demonstrated a larger than 30% improve in efficacy and velocity to efficiency of THC and CBD. Moreover, “FSD,” a feminine sexual dysfunction complement within the firm’s product improvement pipeline, is supported by a scientific trial demonstrating an total reported improve in need, satisfaction, and orgasms in girls.
Timing is every part and Love Pharma has chosen precisely the proper time to affix the extraordinarily in style hashish trade, and extra particularly, the CBD market. In response to analysts at Fortune Enterprise Insights, the worldwide CBD market is projected to develop from roughly $3.7 billion in 2021 to about $55.8 billion in 2028 at a CAGR of 47.49% between 2021 and 2028. The agency attributes the substantial rise in CAGR to demand and development inside the CBD market, producers specializing in formulating new product choices infused with CBD to offer shoppers with easy accessibility, and the market returning to pre-pandemic ranges as soon as the coronavirus pandemic subsides.
In the meantime, the expansion within the CBD merchandise market has been so monumental that main hashish researchers, BDS Analytics and Arcview Market Analysis, are projecting that the collective marketplace for CBD gross sales within the U.S. alone will surpass $20 billion by 2024. One other report by Information Bridge Market Analysis, a number one international market analysis agency, analyzed the CBD-infused edible market and projected it is going to develop at a CAGR of 25% in its forecast interval of 2020 to 2027.
The CEO has the corporate targeted on producing income and rising market share with its patent-protected product portfolio by maximizing international distribution channels, together with direct-to-consumer, retail brick and mortar, on-line outlets and MLM markets. Love Pharma has partnered with in style CBD distributor Love Hemp to launch its manufacturers exterior of North America, and since Zachary Stadnyk may be very aware of the ballooning CBD market within the U.S., Love Pharma has proactively partnered with Potent Ventures to launch each Bloom and Auralief to achieve the rising variety of CBD shoppers within the U.S. market.
Subsequent, within the psychedelic house, Love Pharma is presently growing a biosynthetic psilocybin-infused oral strip. The corporate is utilizing the identical confirmed and current mental property for its psilocybin-infused product that was used to develop the muco-adhesive strip present in Love Pharma’s CBD oral strips.
Psychedelics, like psilocybin, could also be an rising market, however in line with a report from Analysis and Markets, it’s an exploding market. In its report, the agency estimates the dimensions of the psychedelics market to achieve $10.75 billion by 2027, up from simply $4.75 billion final yr and rising at a CAGR of 12.36% in the course of the report interval of 2021-2027.
Lastly, Love Pharma is about up for achievement with its entrance into each the psychedelic and cannabis-infused markets, however its distinctive strategy ought to segue properly into the profitable sexual well being and wellness market too. Sexual well being and wellness can embody a variety of merchandise from sexual enhancement to sexual dysfunction to lubricants. Love Pharma has developed and continues to develop intimate enhancement merchandise to extend circulation whereas offering anti-inflammatory advantages.
The worldwide sexual well being and wellness market is estimated to develop quickly in line with a report revealed by Analysis and Markets final month. Within the report, Analysis and Markets acknowledged that amid the COVID-19 disaster, the worldwide marketplace for sexual well being and wellness, estimated at $30 billion in 2020, is projected to achieve a revised market dimension of $41.6 billion by 2027, rising at a CAGR of 4.8% over the evaluation interval 2020-2027. The report highlights the U.S., China, Canada, Japan, and Germany as noteworthy fast-growing geographic markets within the trade.
Love Pharma is ideally located to develop and to develop shortly because it competes in three separate markets which can be every having fun with their very own unbelievable development. The acute recognition of the merchandise that the CBD, psychedelic, and sexual well being and wellness markets entice present no indicators, by any means, of slowing, and are perfect for Love Pharma to maneuver into and set up their very own footprint inside every of those industries.
To be taught extra about Love Pharma Inc., go to https://love-pharma.com or e mail investors@love-pharma.com
About Love Pharma Inc.
Love Pharma Inc. is a Canadian Securities Change-traded firm. The brand new-age pharma/nutraceutical firm is specializing in international sexual well being, wellness, and psychedelics markets. Based in 2020, Love Pharma’s mission is to carry modern merchandise to market that improve sexual well being and wellness whereas offering an improved high quality of life. Love Pharma holds unique licenses to provide, market, package deal, promote, and distribute patent-protected therapeutic and pharmaceutical merchandise all through Europe, the UK, and North America. Love Pharma anticipates rising worth for its shareholders by way of continued mergers and acquisitions that complement its sturdy portfolio of mental property.
About Inventory Market Media Group
Inventory Market Media Group is a information and media content material improvement IR agency providing a platform for company tales to unfold within the media with press releases, characteristic information articles, analysis stories, company movies, and radio-style CEO interviews.
This text was written primarily based on publicly out there info. Inventory Market Media Group could, now and again, embody our personal opinions in regards to the firms, their enterprise, markets and alternatives in our articles. Any opinions we could provide about any of the businesses we write about are solely our personal and are made in reliance upon our rights beneath the First Modification to the U.S. Structure, and are offered solely for the overall opinionated dialogue of our readers. Our opinions shouldn’t be thought of to be full, exact, correct, or present funding recommendation, or construed or interpreted as analysis. Any funding choices it’s possible you’ll make regarding any of the securities we write about are solely your accountability primarily based by yourself due diligence. Our publications are offered solely as an informational assist, and as a place to begin for doing extra impartial analysis. We encourage you to take a position fastidiously and browse the investor info out there on the website of the U.S. Securities and Change Fee at www.sec.gov. We additionally suggest, as a normal rule, that earlier than investing in any securities, you seek the advice of with an expert monetary planner or advisor, and it’s best to conduct an entire and impartial investigation earlier than investing in any safety after prudent consideration of all pertinent dangers. We’re not a registered dealer, seller, analyst, or advisor. We maintain no funding licenses and should not promote, provide to promote, or provide to purchase any safety. Our publications about Love Pharma usually are not a advice to purchase or promote a safety.
Ought to Inventory Market Media Group and its administration personal shares within the profiled firm, they could profit from any improve within the share worth of the profiled firms and maintain the proper to promote the shares purchased at any given time together with shortly after the discharge of the corporate’s profile. Part 17(b) of the 1933 Securities and Change Act requires publishers who distribute details about publicly traded securities for compensation, to reveal who paid them, the quantity, and the kind of fee. Below the Securities Act of 1933, Part 17(b), Inventory Market Media Group discloses that it was remunerated one-thousand, 200 {dollars} paid for by a 3rd social gathering by way of financial institution wire, to provide this content material associated to Love Pharma.
Inventory Market Media Group and its administration don’t personal any shares in Love Pharma and by no means accepts compensation in free-trading shares for its advertising providers of the corporate being profiled, nevertheless third events which have compensated Inventory Market Media Group could maintain free-trading shares of the corporate being profiled and will very properly be promoting, holding or shopping for shares of the corporate’s inventory on the similar time the content material is being disseminated to potential traders; this must be considered as a particular battle of curiosity and as such, the reader ought to take this into consideration.
If Inventory Market Media Group ever accepts compensation within the type of free buying and selling shares of the corporate being profiled and decides to promote these shares into the general public market at any time earlier than, throughout, or after the discharge of the corporate’s profile, our disclaimer will probably be up to date accordingly to replicate the present place of any free buying and selling shares acquired as compensation for our providers.
For extra info: www.stockmarketmediagroup.com
CONTACT: Contact: Inventory Market Media Group information@stockmarketmediagroup.com
